Podcasts about Prostate cancer

Matt Smith, 42, metastatic prostate cancer, Wilmington, NC, with Michael Serzan, Medical Oncologist, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

For people diagnosed with cancer, patient advocacy can play a vital role throughout the treatment process. At UC San Diego's annual Prostate Cancer Patient Summit, keynote speaker and three-time MLB All-Star David Justice brought visibility and purpose to that message, underscoring the broad reach and lasting importance of speaking up for patients and families. [Health and Medicine] [Show ID: 41648]

For people diagnosed with cancer, patient advocacy can play a vital role throughout the treatment process. At UC San Diego's annual Prostate Cancer Patient Summit, keynote speaker and three-time MLB All-Star David Justice brought visibility and purpose to that message, underscoring the broad reach and lasting importance of speaking up for patients and families. [Health and Medicine] [Show ID: 41648]

For people diagnosed with cancer, patient advocacy can play a vital role throughout the treatment process. At UC San Diego's annual Prostate Cancer Patient Summit, keynote speaker and three-time MLB All-Star David Justice brought visibility and purpose to that message, underscoring the broad reach and lasting importance of speaking up for patients and families. [Health and Medicine] [Show ID: 41648]

For people diagnosed with cancer, patient advocacy can play a vital role throughout the treatment process. At UC San Diego's annual Prostate Cancer Patient Summit, keynote speaker and three-time MLB All-Star David Justice brought visibility and purpose to that message, underscoring the broad reach and lasting importance of speaking up for patients and families. [Health and Medicine] [Show ID: 41648]

What if everything men are told about a prostate cancer diagnosis, biopsy first, surgery next, is built on evidence that was never actually there?In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. Stephen Petteruti, board certified family physician and author of Fight Cancer Like a Man, to break down the 2023 New England Journal of Medicine study that found no survival difference between surgery, radiation, and doing nothing at all for early stage prostate cancer. Dr. Petteruti explains why he stopped recommending biopsies, how a needle can spread the very cancer it's meant to detect, and why watching PSA and MRI trends over time is often safer than rushing into treatment. He also covers the overlooked role of testosterone in prostate cancer care, including bipolar androgen therapy, and makes the case for tracking the disease like a chronic condition instead of chasing a cure that costs a man his vitality.If you or someone you love is facing a prostate cancer diagnosis, or just navigating an elevated PSA, this conversation lays out the questions worth asking before agreeing to anything.Key Takeaways:0:00 Introduction2:33 The prostate trial that shattered the surgery-first model5:19 Why a biopsy can spread the very cancer it's meant to find8:23 Castration's hidden cost on testosterone and quality of life17:12 Tracking prostate cancer with MRI and PSA instead of biopsy21:58 Repurposed drugs and why DIY protocols backfire38:10 BAM therapy: using testosterone as a weapon against advanced cancer Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902Resources:Fight Cancer Like a Man (book) - https://www.intellectualmedicine.com/dr-stephen-petteruti-booksIntellectual Medicine, Dr. Petteruti's practice - https://www.intellectualmedicine.com/The Prostate Protocol - https://assets.ctfassets.net/psmhuxrqomif/4iFYGN6rh0cloFTQyxdit9/a2c3e8e20e335df0ad22f70ca0e0af48/the-prostate-protocol-pdf.pdfProtecT Trial, New England Journal of Medicine, 2023 - https://www.nejm.org/doi/full/10.1056/NEJMoa2214122Johns Hopkins Bipolar Androgen Therapy Research - https://www.hopkinsmedicine.org/news/articles/2023/12/bipolar-androgen-therapy-trials-under-way Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions.

Featuring perspectives from Dr Wassim Abida, Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Rana R McKay, moderated by Dr McKay, including the following topics: Introduction (0:00) Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Antonarakis (2:42) Current and Future Hormonal Treatment for Metastatic HSPC (mHSPC) — Dr Aggarwal (26:23) Current and Future Role of Regimens Combining PARP Inhibitors and Androgen Receptor (AR) Pathway Inhibitors in Metastatic Prostate Cancer — Dr Abida (53:01) Emerging Role of AKT Inhibition for Patients with mHSPC — Prof Fizazi (1:17:22) Current and Future Use of Radiopharmaceuticals in Metastatic Prostate Cancer — Dr McKay (1:39:37) CME information and select publications

A prostate cancer diagnosis affects more than physical health. Learn how emotional support, evidence-based coping strategies, and community resources help patients and caregivers navigate treatment, recovery, and long-term well-being. For more information, visit https://prostaid.org/meetings/ Prostaid Calgary City: Calgary Address: 1600 90 Avenue Southwest Website: https://prostaid.org/

Episode Overview:  Steve Fisher is 77 years old, lives in Nebraska, and has been through more than most men can imagine. In 2020, he and his wife were both diagnosed with cancer at the same time. Her lung cancer surgery was followed by a catastrophic complication, and Steve lost her in late 2020, while still carrying his own prostate cancer diagnosis.  In the first half of 2021, Steve went ahead with treatment: low-dose brachytherapy (permanent seed implants) followed by 20 sessions of external beam radiation, plus a short course of Lupron (a prescription hormonal therapy). His PSA is now sitting at 0.04. Cancer-wise, things are excellent.  But nobody told Steve what was coming next. No one talked to him about erectile dysfunction, penile rehabilitation, vacuum pumps, constriction rings, or the emotional weight of losing sexual function on top of losing a partner. He navigated that on his own, with little support from his healthcare team.  Then in May 2026, Steve stumbled across Victoria Cullen's website A Touchy Subject on YouTube, joined The Hub, and things started to shift. He ordered daily Cialis and a Soma OT medical-grade vacuum pump — the right equipment, with the right information about how constriction rings work in combination with a pump. Within two months, Steve and Carol were having penetrative sex again for the first time in years.  This episode is also about the emotional and psychological side of this journey — the anxiety men carry silently, the male ego dimension of losing erectile function, and the importance of community, peer support, and simply having someone to talk to who understands.  This is a warm, funny, honest, and genuinely hopeful conversation about grief, finding love again, getting information too late, and what happens when a man finally gets the right tools and the right support.   Golden Tip: How to use the pumps with a constriction ring successfully, including Steve's tip about lubricant on the outside of the cylinder.     In This Episode, We Cover  Options when PDE5i (Viagra etc) don't work   The difference between medical-grade vacuum pumps and sex toys   Why injections (Trimix) failed for Steve and what was missing from the picture  Constriction rings: the information that changed everything- Golden Tip even Melissa learnt something new!  Finding love again in later life and navigating intimacy with a new partner  The mental and emotional toll of erectile dysfunction, the side no one talks about enough  Victoria Cullen's community The Hub, and why peer support matters  Steve's new YouTube channel: Everyday Prostate Cancer Warrior   Key Message from Steve  Steve's closing message is about the emotional and mental burden men carry through this. Cancer treatment gets you through the door. But the anxiety, the silence, the feeling that you should just be grateful you're alive that stays with men for years. Steve wants other men to know it is acceptable to talk about it, to seek support, and to keep going. He had almost given up entirely. Finding the right community, the right information, and the right equipment changed everything.    Resources & Links  The Hub – Victoria Cullen's online community for men navigating prostate cancer recovery and intimacy: A Touchy Subject / The Hub  Steve's YouTube channel – personal stories and practical experience from a prostate cancer survivor: Everyday Prostate Cancer Warrior on YouTube  Book a telehealth appointment with our sexual health nurse practitioners at Restorative Health Clinic  For more information check out our websites www.rshealth.com.au , www.makehardeasy.com.au and www.melissahadleybarrett.com.au   Steve Fisher YouTube link to his Everyday Prostate Cancer Warrior. https://youtu.be/APLm1W8uPBA?si=SfaA9A74GqMNcvUq  Click here to shop the Sompatherapy Pumps: The Touch II Automatic Pump, and the Response II Manual Pump  Click here to watch Melissa's YouTube video: Most Men Use the SOMA VED Wrong | Here's the Correct Way    Book a telehealth consultation with our sexual health nurse practitioners:  Restorative Health Clinic    For more information visit our websites:  www.rshealth.com.au  www.makehardeasy.com.au  www.melissahadleybarrett.com    Need Support?  At Restorative Health Clinic, we support men and their partners with:  Penile rehabilitation after prostate cancer treatment  Erectile dysfunction  Vacuum pump and constriction ring education and prescription  Penile injection therapy  Intimacy and sexual recovery  Partner-inclusive support where appropriate  Practical, evidence-based strategies for rebuilding confidence and function    We offer telehealth consultations Australia-wide and internationally, making it easier for men to access experienced, compassionate support no matter where they live. If Steve's story sounds familiar, we would love to hear from you.    Restorative Health Clinic also has a psychologist-sexologist joining the team. If you are struggling with the emotional or psychological side of erectile dysfunction, prostate cancer recovery, or intimacy, we can support you there too – as an individual or as a couple.    Listen & Subscribe  If you found this episode helpful, please subscribe, rate, and review The Penis Project Podcast. Your feedback helps more men and their partners find these conversations. Search for The Penis Project Podcast on Spotify, Apple Podcasts, or your favourite podcast app.    We also have a free email list for updates, episodes, and resources. You can sign up via our website.     Connect With Us  We love hearing from real people navigating their health. If you would like to share your story or ask a question, get in touch.    Email: admin@rshealth.com.au    Websites:  rshealth.com.au   makehardeasy.com.au  melissahadleybarrett.com    Instagram:  @melissahadleybarrett  @restorativehealth.clinic    YouTube:  Melissa Hadley Barrett    TikTok:  @melissahadleybarrett    Facebook:  Melissa Hadley Barrett  Restorative Health Clinic    LinkedIn:  Melissa Hadley Barrett    TEDx Talk:  Watch on YouTube 

In this episode, UROONCO PCa associate editor Dr. Jennifer Le Guévelou speaks with radiation oncologist Prof. Pierre Blanchard on the results of the PEACE 2 phase III randomised trial investigating prophylactic pelvic radiotherapy (RT) targeting pelvic nodal micrometastases and/or cabazitaxel may both reduce the risk of relapse and improve outcomes in patients with very high-risk localised prostate cancer.They discuss the design of the PEACE 2 trial, and its key findings, which showed that whole-pelvic radiotherapy yielded only a minimal trend towards improving clinical progression-free survival, with no significant impact on secondary endpoints, including metastasis-free survival and overall survival. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Hosts: Ed Jones (Owner – Nutrition World) & Clint Powell A variety of topics to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: Beyond Cholesterol: The Heart Health Markers That Matter [0:00:00] – Intro: Lettuce Contamination, Social Media & Local Business Impact Discussion of “fear of lettuce,” limited to 15 states (not Tennessee) How social media amplifies food scares Local “Build a Salad” restaurant going out of business and timing around lettuce scare [0:04:39] – Back-to-School Immune Support: Oral Probiotics & Iodine Nasal Spray Back-to-school season and rise in colds/sicknesses Oral probiotics for kids: oral microbiome, throat/sinus benefits Iodine nasal spray for parents and teachers: safety, use during school/gym, personal routines of Ed and Clint [0:08:04] – Supplement Industry & Big Pharma Buyouts Thorne bought by Procter & Gamble for $3.8B History of pharma mocking “granola/hippie” supplement culture, now buying brands Many acquired supplement brands failing under pharma ownership Difference between pharma customers and nutraceutical users (education, mindset) Nutrition World's preference for privately owned brands [0:14:00] – Life Lessons from Flying & Racing: Doing the Hard but Right Thing Ed's story: practicing engine-out landings, re-learning best glide speed Insight: sometimes you must “point the nose down” (do the counterintuitive hard thing) to survive Clint's race-car analogy: “you go where you look” – look down the track, not at the wall [0:18:01] – Food Label Claims: Olive Oil vs. Avocado Oil Products UC Davis testing of products “made with olive oil” – most passed authenticity tests Avocado-oil-labeled products often failing purity tests Takeaway: be more skeptical of “made with avocado oil” claims [0:18:31] – Prostate Cancer & “Treating the Terrain,” Not Just the Tumor Dr. Gio (prostate-focused naturopath): focus on the ground cancer grows in Historical context from Stephen Paget's work on tumor “soil and seed” Lifestyle “soil-building” recommendations: Resistance training, walking 150 minutes/week Waist circumference < half your height Sleep, stress reduction, nutraceuticals, nutrient-dense diet [0:21:58] – Multivitamins, Carotid Stenosis & Functional Benefits COSMOS study: Centrum multivitamin and patients with carotid narrowing Reported improvements in physical function (walking, climbing stairs) and symptoms (shortness of breath, fatigue) Ed's extrapolation: better-designed multis (True Grace, Life Extension, etc.) likely offer even more benefit [0:22:30] – Post-Infectious Cough: Honey + Instant Coffee vs. Prednisone Double-blind RCT comparing: Honey + instant coffee paste Prednisone Guaifenesin Honey + instant coffee dramatically outperformed prednisone in reducing persistent cough frequency Discussion of guaifenesin's role, safety, and its regulatory history in health food vs. pharmacy channels [0:30:12] – Prednisone, COVID & Anxiety: Personal Case Story Guest Dr. Curt Dearing shares: Followed COVID protocol including prednisone Developed severe, prolonged anxiety afterward (twice) Realization that prednisone triggered it Ed's summary of prednisone side effects: bone loss, cataracts, muscle wasting, weight gain; okay short term, risky long term [0:33:30] – Cardiovascular Disease, Statins, & New Drug Lifendra (PCSK9 Inhibitor Pill) CV disease framed as leading cause of death for most people Introduction of Lifendra (oral PCSK9 inhibitor, from Merck) as “breakthrough” LDL-lowering drug Comparison with Repatha (injectable PCSK9 inhibitor) Curt's key points: Lifendra lowers LDL but does not show reduction in cardiovascular death, heart attack, or stroke (per Merck's own wording so far) Repatha's trial data: minimal impact on non-fatal events; no reduction in CV deaths vs. placebo Very high cost (~$300+/month out of pocket; heavy insurance burden) Critique of LDL obsession in cardiology Need to ask: Why is the cardiovascular system inflamed and oxidized? Ed & Curt's “terrain” model: Bad inputs: ultra-processed food, toxins, poor sleep, chronic stress, lack of sun/movement Missing inputs: nutrient-dense foods, minerals, omega-3s, organ meats, sunlight, sleep, movement Example of amlodipine: lowers BP numbers but may increase arterial calcification (calcium channel blocker) For people unwilling to change lifestyle, drugs may offer marginal benefit—but not true health [0:41:05] – Curt's Book & Lab Markers That Matter More Than LDL-C Curt's book: “Beyond Cholesterol: The Ultimate Guide to Testing and Supplements for Heart Health” Emphasis on better markers: ApoB, LDL particle size/number, calcium score, etc. Book's Amazon performance briefly noted (new release bestseller in its category) [0:44:32] – Alternatives to Statins & PCSK9s: Bergamot & Lifestyle Curt's hierarchy: Lifestyle (diet, exercise, stress, sleep) Targeted supplements like bergamot (citrus extract): lowers harmful particles such as ApoB and supports “good” LDL function Only then consider pharmaceuticals, and very selectively Skepticism about recommending Lifendra at all; strong bias toward non-drug approaches [0:45:28] – Dr. Wolfson, Mold, and Cardiovascular Terrain Ed & Curt's respect for Dr. Jack Wolfson, “The Natural Heart Doctor” Mention of mold as a major, under-recognized driver of cardiovascular disease Reference to Dr. Wolfson's educational resources and upcoming podcast plans [0:48:04] – Key Takeaways on Lifendra & Heart Prevention Strategy Lifendra will not fix: seed oils, glyphosate exposure, mold, bad sleep, chronic stress Terrain-building priorities: Real food, omega-3s, sunlight Toxin reduction Mitochondrial support Foundational supplements Contrast: drugs = band-aids with side effects; nutraceuticals = “side benefits” when used correctly [0:52:28] – Wrap-Up Ed mentions Sprouts selling lab-grown meat and his strong opposition Update on Oura Ring: now tracking nighttime blood pressure and importance of BP dipping Listener story: young man post–heart surgery credits Nutrition World's education and support with changing his life Final thanks to Dr. Dearing and closing outro  The post Radio Show / Podcast – August 9, 2026 first appeared on Vital Health Radio.

The son of former President Joe Biden has an update on his father's health. AP correspondent Donna Warder reports.

For David Peters, what began as medical attention to address an enlarged prostate in 2022 became a diagnosis of Stage 4B prostate cancer.  Prior to his undergoing a Rezum procedure, a pre-op workup a PSA level of 19.  However, nobody at the hospital bothered to check the PSA level before performing the procedure, which placed David at great risk.  Not long after that came his diagnosis.  David's care team recommended lifelong androgen deprivation therapy.  He checked out the side effects and didn't want to go that route.  David instead opted for a three-week to Hope4Cancer in Cancun, Mexico, where he underwent an intense holistic regimen.  In 2026, when the cancer spread to his bones, he went to the First Nations Clinic in Tennessee, where he is undergoing a nanotherapeutics protocol.  It is keeping the cancer at bay, and he enjoys a healthy lifestyle.   David said his cancer journey did not begin with cancer symptoms.  The combination of frequent urination and a weak stream led him to believe he had an enlarged prostate and went to a doctor.  He had many options, but chose a Rezum procedure, in which steam into the prostate through the rectal wall and it shrinks the prostate.  However, the care team wanted to first make sure David didn't have prostate cancer, so he was given a PSA test.  This was in May of 2022.  In August, the surgery was performed; but it wasn't until September that a nurse informed him that his PSA level was dangerously high at 19, meaning the surgery was performed when his risk for cancer was high, but the care team didn't know it!   Not long after that, David Peters was diagnosed with Stage 4B prostate cancer, which had spread to his sacrum, iliac chain and a node near his rib cage.  His oncologist discussed with Dave various treatment options, but urged him to immediately begin a regimen of androgen deprivation therapy, which would basically shut off his testosterone.  It did not David and his wife, Kathi, to agree this was not the way to go, and they opted to see remedies that were more holistic in nature.   After some research by David and Kathi, they decided to Hope4Cancer in Mexico, where he would undergo intensive testing and holistic work.  He really appreciated that Hope4Cancer treats body, soul and spirit with an eye toward wholeness.  He experimented with a raw vegan diet and with fasting.  David ended up being more diligent about the meats and vegetables he ate.   David continued his cancer journey in February 2026 at the First Nations Clinic in Tennessee, where he began a protocol of nanotherapeutics.  They disrupt the cancer cells, and for the first time in three years his PSA went down.  He goes to the clinic once a month.   David Peters is happy to report he weighs 150 pounds, like he did in high school.  He walks every day, exercises three times and does pushups every day.   Additional Resources:   David's Website: https://www.threewordsdoc.com        

Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard. Timestamps: 01:05 – Traditional diagnostic approaches 02:55 – PRECISION trial 05:03 – MRI challenges

In the final episode, Veeru Kasivisvanathan discusses the future of prostate cancer diagnosis, including AI-assisted MRI interpretation, genomic risk prediction, polygenic risk scores, and the opportunities and challenges of population screening. Discover how precision technologies could reshape prostate cancer care over the next decade. Timestamps: 00:57 – AI and MRI 02:25 – PARADIGM study 02:51 – Large-scale MRI screening 04:56 – Genomics and polygenic risk scores 06:45 – Future optimism of prostate cancer

Death is a topic most of us avoid...until we can't.But what if talking about it early actually gave us more peace, not less? In this episode, Leah sits down with Dr. Susan Abernethy, founder of Mudança Healing, whose path from naturopathic medicine and nonprofit leadership (including Make-A-Wish) led her to become an end-of-life doula.Susan shares how having honest conversations early, especially after a cancer or dementia diagnosis, can ease the pressure of rapid-fire medical decisions, bring clarity to what really matters, and offer real comfort to both patients and the families who love them. We get into the practical side too: the gaps hospice care often leaves behind, the toll caregiving takes on families, and why services like respite matter so much. Susan also walks us through the tools she uses in her workshops—from Death Decks to checklists—to help individuals and organizations get ready for what's ahead, not just legally, but practically and emotionally.This conversation is a gentle reminder: planning for the end isn't morbid. It is an act of care for the people you love.Connect with Susan: www.mudancahealing.comand on Instagram @mudanca_healingResources mentioned in this episode:All There Is with Anderson Cooper https://podcasts.apple.com/us/podcast/all-there-is-with-anderson-cooper/id1643163707Death, End-of-Life, and Dementia Decks https://thedeathdeck.com/collections/shop-all-decksA Good Death by Margaret Rice https://bookshop.org/a/103670/9781911632146Learn more about end-of-life doulas at https://inelda.org/Leave a message and let us know what you liked about the episode!Support the showBecome a member of The Cancer Pod Community! Support the podcast and gain access to exclusive content and more! Join today on Buy Me a Coffee or Patreon.Check out thecancerpod.com! Looking for more information? The website has blogs, merch, and all of the episodes listed by season and category. Shop the Bookshop! The shelves at Bookshop feature books by authors who have been on the show and other fav books.Buy The Cancer Pod merch! Whether it's a cozy hoody or a handy water bottle, we have something for everybody.Have a comment or suggestion? Email info (at) thecancerpod (dot) com Follow @TheCancerPod on social media:InstagramBlueskyFacebookLinkedInYouTube

In this podcast episode, the speakers discuss how the findings from the EMBARK clinical trial could translate into real world practice.

Book a free consultation with Robert Sikes to break through your keto or low-carb plateau: https://www.ketobodybuilding.com/callA fit, strong body can still be unhealthy below the surface, and more biohacking may never fix the cause. In episode 906 of the Savage Perspective Podcast, host Robert Sikes sits down with Kash Kahn to reveal why fitness and health are not the same. They explore environmental toxins, mold exposure, gut health, chronic inflammation, mitochondrial function, genetic testing, hormones, TRT, male fertility, seed oils, metabolic health, and longevity. Kash explains why removing harmful inputs may matter more than adding treatments, and how your genes, food, home, stress, movement, and daily habits can shape long-term health. Watch to learn what common fitness markers may miss.Follow Kash on IG: https://www.instagram.com/kashkhanofficial/Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters0:00 - What Is the Difference Between Health and Biohacking?1:15 - What Is the Biggest Hidden Threat to Your Health?2:45 - Can 5G Make Mold Exposure More Harmful?4:02 - Why Modern Homes and Food May Harbor More Mold6:12 - Can You Detox Faster Than Toxins Accumulate?7:02 - IBU vs. INUSpheresis: Blood Treatments Explained8:02 - When Will Advanced Blood Filtration Become Affordable?9:32 - Will Male Fertility Disappear by 2045?11:32 - What Is Driving the Male Fertility Crisis?11:59 - Why “Safe” Chemical Studies Miss the Real Risk14:15 - How to Find Safer Natural-Fiber Clothing15:13 - Which Health Tests Should You Get First?19:02 - The Lower-Cost Way to Optimize Your Health21:01 - How Long Should Humans Actually Live?25:38 - Is Purpose the Most Underrated Longevity Tool?26:40 - How Movement Strengthens Bones, Lymph, and Mental Health30:13 - What Really Causes Breast and Prostate Cancer?36:11 - Is HRT Safe? Why Genetics May Change the Answer38:40 - Why TRT Can Fail: A Former NHL Player's Case42:25 - Is There a Species-Appropriate Human Diet?47:10 - Why Seed Oils and Glyphosate May Damage the Gut49:50 - How to Avoid Seed Oils Without Being Perfect51:02 - How Accurate Are Consumer Genetic Tests?54:37 - How Epigenetics Can Affect Future Generations57:05 - Why the Future of Healthcare Is Based on Signals59:22 - Can Natural Nutrients Replace Injectable Peptides?1:01:06 - The Correct Order for Biological Age Reversal1:03:23 - Where to Follow the Kash and Learn More

In this rapid-fire episode, Veeru Kasivisvanathan answers key questions on prostate cancer diagnosis, MRI, prostate biopsy, overdiagnosis, AI, and future innovations. From common misconceptions to emerging technologies, this concise episode delivers expert insights into one of the fastest-evolving areas of urology.

Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard. 01:05 – Traditional diagnostic approaches 02:55 – PRECISION trial 05:03 – MRI challenges

In this episode, UROONCO PCa chief editor Dr. Giancarlo Marra interviews Prof. Mary-Ellen Taplin from Dana–Farber Cancer Institute in the United States, on the results of the PROTEUS trial. The PROTEUS trial is a phase 3, double-blind, placebo-controlled trial evaluating the benefit of adding apalutamide to standard androgen deprivation therapy (ADT) in men with high-risk, localised prostate cancer undergoing radical prostatectomy.They discuss the rationale, patient selection and the results of this trial (dual primary endpoint), as well as the impact of the results on clinical practice. Prof. Taplin concludes in the take-home messages that this trial has illustrated the progress being made in regard to preventing and delaying relapse.To know more on this trial, read the abstract with expert commentary by UROONCO PCa associate editor Assoc. Prof. Pawel Rajwa. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

See omnystudio.com/listener for privacy information.

In this episode of CURiE Conversations, host Dr. Jessica Schuster speaks with Dr. Veronia Fahmy and Dr. James S. Welsh about their published work, "Small-Cell Carcinoma of the Bladder With Concurrent High-Grade Prostate Cancer: A Case Report and Review of the Literature."The discussion explores the management of this rare synchronous malignancy, the rationale for bladder-preserving chemoradiotherapy, the role of hypofractionated radiation and the clinical decision to use MRI surveillance instead of prophylactic cranial irradiation. They also reflect on how reviewing the limited literature surrounding rare cancers helped guide treatment.Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science. Read the full article here: https://www.cureus.com/articles/502342-small-cell-carcinoma-of-the-bladder-with-concurrent-high-grade-prostate-cancer-a-case-report-and-review-of-the-literature

Prostate cancer remains one of the most common cancers affecting men. The good news is that screening, diagnosis, and treatment have all advanced significantly in recent years. Gina Carithers, CEO of the Prostate Cancer Foundation told me where we're still failing. AND, already this year, 12 children in the United States have died after being left in or becoming trapped inside hot cars. Laura Dunn, Senior Safety Specialist with the National Highway Traffic Safety Administration, explained how it happens and how we can prevent a tragedy. See omnystudio.com/listener for privacy information.

What if hitting prostate cancer earlier and harder is the key to delaying disease progression and sparing patients from invasive salvage therapies? In this follow-up to his i3 Health Virtual Tumor Board, Stephen Freedland, MD, Cedars-Sinai Medical Center, unpacks practice-changing data from ASCO that is actively reshaping care algorithms across the prostate cancer continuum. Dr. Freedland dives into the breakthrough TALAPRO-3 trial—exploring why talazoparib plus enzalutamide is making waves across diverse HRR alterations (including BRCA and ATM)—and analyzes how the PROTEUS trial's 35% reduction in subsequent salvage therapies could redefine surgical planning for high-risk localized disease. Plus, get an insider's look at what's on the horizon with PSMA PET imaging, T-cell engagers, and AR degraders.

For decades, men with high-risk prostate cancer have routinely been told they need 18 to 36 months of androgen deprivation therapy (ADT) alongside radiation.But what if 12 months is enough?In this episode of the Dr. Geo Prostate Podcast, Dr. Geo Espinosa welcomes internationally recognized radiation oncologist Dr. Dan Spratt, Chair of Radiation Oncology at University Hospitals/Case Western Reserve University, to discuss groundbreaking research that could change how advanced prostate cancer is treated.Together they explore the latest MARCAP consortium data suggesting many men may receive the same cancer control with significantly less hormone therapy—potentially reducing years of unnecessary side effects while maintaining excellent outcomes. They also discuss how physicians personalize treatment decisions, the growing role of artificial intelligence with Artera AI, and why the future of prostate cancer treatment may involve doing less, not more.If you or someone you love is facing radiation therapy for prostate cancer, this episode provides one of the most important conversations happening in prostate cancer care today.What You'll Learn✔ Why 2-3 years of ADT may not be necessary for many patients✔ The new evidence supporting approximately 12 months of hormone therapy✔ Why longer hormone therapy can permanently affect testosterone recovery✔ How physicians balance cancer control with quality of life✔ The difference between NCCN guidelines and individualized patient care✔ Which patients may still benefit from longer hormone therapy✔ How AI (Artera AI) is helping personalize prostate cancer treatment✔ Why prostate cancer care is shifting toward treatment de-intensification✔ The future of precision medicine in radiation oncologyEpisode Timestamps00:00 Introduction01:30 Meet Dr Dan Spratt02:22 Why ADT Lasts Years05:42 How ADT Helps Radiation08:49 Personalizing ADT Duration12:39 Guidelines and Real World Use18:03 Who Needs Long Term ADT21:13 Artera AI Explained23:19 Old Data and Modern Outcomes27:28 De Intensification Future31:33 Biomarkers for Urologists33:57 Choosing Artera vs Decipher37:28 Final Takeaways and OutroKey Discussion PointsNew MARCAP consortium analysis on ADT durationRadiation sensitivity and androgen deprivationWhy many men never fully recover testosterone after prolonged ADTBalancing survival outcomes with quality of lifeShared decision-making between physician and patientGenomic classifiers including DecipherAI biomarkers and Artera AIPersonalized radiation oncologyModern imaging and PSMA PETDe-intensifying prostate cancer treatmentPrecision medicine in localized prostate cancerThe future of individualized prostate cancer careResources Mentioned• MARCAP Consortium research on androgen deprivation therapy duration• NCCN Prostate Cancer Guidelines (discussed throughout the episode)• Artera AI clinical decision support platform (discussion)• Decipher genomic classifier• PSMA PET imaging• MRI-guided prostate cancer staging___________________________________

Jerry McCormick, longtime journalist, educator, and prostate cancer survivor, shares how he transformed a life-threatening diagnosis into a mission to educate Black men about early prostate cancer detection and proactive healthcare. Jerry chats about the cultural barriers to care, the power of honest storytelling and his work to build support networks and advocacy platforms for men's health. Listen Where You Live!About Spotlight and Cloudcast Media  "Spotlight On The Community" is the longest running community podcast in the country, continuously hosted by Drew Schlosberg for 20 years.  "Spotlight" is part of Cloudcast Media's line-up of powerful local podcasts, telling the stories, highlighting the people, and celebrating the gravitational power of local.   For more information on Cloudcast and its shows and cities served, please visit www.cloudcastmedia.us. Cloudcast Media | the national leader in local podcasting.   About Mission Fed Credit Union  A community champion for over 60 years, Mission Fed Credit Union with over $6 billion in member assets, is the Sponsor of Spotlight On The Community, helping to curate connectivity, collaboration, and catalytic conversations.  For more information on the many services for San Diego residents, be sure to visit them at https://www.missionfed.com/

Dr Bill Nelson and Dr Mike Carducci examine the latest hormone target therapies for prostate cancer, their side effect profiles and the evolution of individualized treatments.

Part of the Top 10 Tour: 100K StrongWhen David Peters was diagnosed with stage four prostate cancer, he and his wife Kathi made an immediate decision: go all-natural. As professional filmmakers, they're now documenting their own healing journey — including treatment at Hope4Cancer in Mexico, biological dentistry to remove mercury amalgams, and the RGCC ("Greek") test that pinpoints which supplements are actually working.Recorded live at Healing Strong's 10th anniversary conference in Houston, this conversation covers the fear of going against an oncologist's orders, the emotional toll (and unexpected gift) of a diagnosis, why community is essential on a healing journey, and what it means to choose to heal rather than fight. David and Kathi also share how their upcoming documentary aims to answer the three questions every newly diagnosed person asks: Can I do it? How do I do it? Will it help me?This episode originally aired as part of our regular series and is being re-shared as one of the most-loved conversations from the I Am Healing Strong podcast archive.HealingStrong's mission is to educate, equip and empower our group leaders and group participants through their journey with cancer or other chronic illnesses, and know there is HOPE. We bring this hope through educational materials, webinars, guest speakers, conferences, community small group support and more.Please take advantage of our FREE resources below to help you along your health and healing journey:Support Group DirectoryHolistic Curriculum - Participant GuideSupport Our Mission - DonateAdditional Health ResourcesListen to Previous EpisodesWebsite: healingstrong.org

We've been told for decades that giving testosterone to a man with prostate cancer is like throwing gasoline on a fire. But what if, in the right context, it actually acts as the extinguisher?” It sounds like medical heresy, yet this is the foundation of Bipolar Androgen Therapy (BAT). Imagine a treatment that intentionally cycles your hormones from extreme highs to extreme lows to "overload" cancer cells and reset their sensitivity to medicine.In this episode, we sit down with a true pioneer of this paradigm shift: Dr. Michael Schweizer. An Associate Professor at the Fred Hutchinson Cancer Center and a key architect behind the original BAT trials at Johns Hopkins, Dr. Schweizer is the scientist moving the bar for men with advanced, castrate-resistant disease. We're moving past the fear-based dogma to look at the clinical data that proves supraphysiologic testosterone isn't just a quality-of-life booster—it's a sophisticated weapon against resistant tumors.In this episode, you'll learn:The "Hormone Shock" Mechanism: How flooding the body with 1,500+ ng/dL of testosterone causes "mitotic catastrophe" in cancer cells adapted to low-androgen environments.The Resensitization Secret: Why cycling BAT can actually "reset" your cancer, making drugs like Enzalutamide work again after they've failed.Precision Selection: Which specific genetic mutations (like TP53) might predict who becomes an "exceptional responder" to high-dose testosterone.The Sequential Strategy: Why the order of your treatments—BAT first, then RPIs—could potentially extend survival by nearly 10 months.⏱️ Chapters00:00 Introduction: Can Testosterone Treat Prostate Cancer? 02:00 The surprising origin of Bipolar Androgen Therapy (BAT) 04:10 ⭐ Stop & Watch: Why Charles Huggins hinted at this decades ago 07:10 Why ordinary testosterone therapy failed—and BAT didn't 08:20 ⭐ Stop & Watch: The BAT protocol explained (400 mg every 28 days) 10:00 Why BAT is only used in castration-resistant prostate cancer 14:05 ⭐ Stop & Watch: The TRANSFORMER trial—did BAT actually work? 16:20 ⭐ Stop & Watch: How BAT may make failed treatments work again 20:30 ⭐ Stop & Watch: If testosterone isn't the enemy...why do we suppress it? 22:10 ⭐ Must Watch: The biology that completely changes how we think about testosterone 24:10 How BAT damages cancer DNA 26:30 BAT, quality of life, and survival—what the evidence really shows 30:00 ⭐ Stop & Watch: The sequencing strategy that could add months of cancer control 31:30 Which patients may respond best to BAT? 33:20 ⭐ Must Watch: Why every advanced prostate cancer patient should consider genetic testing 36:00 Can someone on ADT simply start testosterone? 40:00 Where BAT fits among today's prostate cancer treatments 43:00 ⭐ Stop & Watch: BAT + Lutetium PSMA—the next frontier 45:00 How to find BAT clinical trials 47:00 Should hormone therapy ever be stopped? 53:00 Final thoughts____________________________________

What if the same type of electromagnetic fields we usually discuss as health risks could actually be used to fight cancer? A new study reveals how precisely controlled EMF exposures killed prostate cancer cells in the lab. I'm R Blank, and in this episode of the Healthier Tech Podcast, I break down groundbreaking research showing how extremely low frequency pulsed electromagnetic fields activated tumor suppressor genes and triggered cancer cell death. This represents a fascinating inversion of the typical EMF narrative -- and it's crucial to understand why therapeutic EMF applications are completely different from the environmental exposures we encounter daily. In This Episode How controlled pulsed electromagnetic fields killed prostate cancer cells in laboratory conditions The specific genetic changes that make this therapy work -- including activation of PTEN and BAX genes Why therapeutic EMF is fundamentally different from environmental EMF exposure What this research means for the future of cancer treatment Featured Study Read the full study: Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields See all studies at shieldyourbody.com/research

A prostate cancer diagnosis can bring uncertainty, fear, and stress, but does stress actually make cancer worse? In this episode of the Intellectual Medicine podcast, Dr. Petteruti explores the relationship between stress, mindset, and prostate cancer. He explains the difference between healthy, action-oriented stress and chronic fear, which can diminish the quality of life.Rather than focusing on eliminating stress altogether, Dr. Petteruti encourages listeners to channel anxiety into meaningful action, make informed treatment decisions, and avoid letting cancer dominate every aspect of their lives. He shares personal stories and practical strategies for breaking cycles of worry, maintaining vitality, and preserving a sense of purpose throughout the cancer journey.The discussion also highlights the importance of finding joy, planning meaningful experiences, and avoiding "hedonistic deprivation," the loss of life's simple pleasures in the pursuit of perfect health. Ultimately, this episode is a reminder that while cancer may be part of your life, it doesn't have to define it. By prioritizing vitality, reducing unnecessary fear, and focusing on what you can control, you can improve both your well-being and your outlook.Timestamps:(00:00) Does stress really make cancer worse?(01:03) Healthy stress vs. chronic stress(05:10) A different way to overcome fear(08:45) Don't let cancer beat you twice(10:42) Practical ways to reduce stress(12:48) Why joy is part of your treatment plan(14:20) Planning for happiness while living with uncertainty(15:24) Don't let cancer become your identity(16:41) Living without regret(17:45) Why stress has always been part of the human experienceEnjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.

Diets rich in fruits and vegetables preserve brain function—but in vulnerable persons with the ApoE4 “Alzheimer's gene”, more meat staves off decline, contradicting years of recommendations to minimize animal protein; Supplements for adrenal insufficiency; “Forever chemicals” may weaken teen's bones—but menopausal hormone replacement therapy decisively fends off osteoporosis; Legionnaire's disease strikes poor and affluent alike in New York City; Doctors propose warning labels for GLP-1 drugs on account of this under-appreciated danger.

Mr. Jones from the We Got A Thing podcast called in to talk all about having prostate cancer, losing his erections and then swinging again years later. Tune in to hear how he found out he had prostate cancer despite having zero symptoms, why routine bloodwork and PSA testing probably saved his life, what his MRI, biopsy and Gleason score revealed, why he decided on surgery vs. radiation, what recovery was really like, how long he had to wear a catheter, when he regained bladder control, how and why he lost penis length after surgery, why he could no longer ejaculate, how prostate removal affected his erections and orgasms, why Viagra and Cialis didn't work for him, how Bimix helped him get his sex life back, what it was like returning to the swinging lifestyle after prostate cancer, why communication with his female partners became more important than ever, what every guy should know about PSA testing and prostate cancer screening, plus a whole lot more. To get in touch with him and join his mens only community you can email him at  mr.jones@wegottathing.com ir find them here: https://wegottathing.com GET A COPY OF THE STRICTLY ANONYMOUS BOOK! Strictly Anonymous Confessions: Secret Sex Lives of Total Strangers. A bunch of short, super sexy, TRUE stories. GET YOUR COPY HERE: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://amzn.to/4i7hBCd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  or Pre-order audiobook version ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠   To see HOT pics of my female guests + hear anonymous confessions + get all the episodes early and AD FREE, join my Patreon! It's only $7 a month and you can cancel at any time. You can sign up here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/StrictlyAnonymousPodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and when you join, I'll throw in a complimentary link to my private Discord! To join SDC and get a FREE Trial! click here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.sdc.com/?ref=37712⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or go to SDC.com and use my code 37712 Want to be on the show? Email me at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠strictlyanonymouspodcast@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.strictlyanonymouspodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and click on "Be on the Show." Want to confess while remaining anonymous? Call the CONFESSIONS hotline at 347-420-3579. All voices are changed.   Sponsors:  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://beduc.at/pd2626-anonymous⁠⁠⁠⁠ Click here to take the quiz and  get your personalized SUMMER roadmap to sexual happiness ⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://Rythm.Health/STRICTLYANON⁠⁠⁠⁠⁠⁠ ⁠⁠for 15% OFF your first month  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://VB.Health⁠⁠⁠⁠⁠⁠⁠ - To get 10% off DRIVE BOOST by VB Health, use code: STRICTLY   ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bluechew.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ — Buy 2 months of Bluechew GOLD and get the third month FREE! Use code: STRICTLYANON⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Follow me! Instagram  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/strictanonymous/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ X  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/strictanonymous?lang=en⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.strictlyanonymouspodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Everything else: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/Strictlyanonymouspodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this episode of BackTable Urology, host Dr. Tiwa Akinsola is joined by Dr. George Schade from the University of Washington to explore focal therapy as a middle ground between active surveillance and radical treatments. Dr. Schade reviews non-radiation energy modalities including HIFU, TULSA/HI-DU, cryotherapy, and irreversible electroporation, highlighting patient selection, institutional experience, technical nuances, and quality-of-life outcomes from recent trials. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps00:00 - Introduction02:09 - Overview of Focal Therapy Modalities04:46 - Deciding Between HIFU and IRE06:56 - Evidence and Trials09:40 - Counseling Patients on Outcomes12:09 - Building a Focal Therapy Program16:12 - Navigating Insurance and Appeals21:48 - Managing Large Glands And TURP25:12 - Preop Workup Essentials and OR Workflow32:32 - Overcoming the Learning Curve35:52 - PostOp Recovery and Surveillance39:04 - Options for Managing Recurrence42:44 - Challenges with Repeat Ablation44:56 - Final Takeaways --- More about this episodeThe conversation covers candidate selection and confirmatory biopsy, perioperative technique and recovery, and ongoing surveillance with PSA, MRI, and biopsy. Dr. Schade also discusses challenges with insurance approvals, building a focal therapy practice, and options for managing recurrence, including repeat ablation, surgery, or radiation. The episode examines how to balance cancer control with quality of life and reviews the evolving evidence base supporting focal therapy's role in prostate cancer treatment. --- Resources Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial:https://www.sciencedirect.com/science/article/pii/S030228382500346X Focal therapy of localized prostate cancerhttps://pubmed.ncbi.nlm.nih.gov/35996758/ Focal Therapy for Prostate Cancer: Available Technologies, Patient Selection, Follow-Up Protocols and Reported Outcomeshttps://pubmed.ncbi.nlm.nih.gov/41339218/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.► https://www.backtable.com/app

In this episode of The Dr. Haley Show, Dr. Michael Haley speaks with Michael Bovarnick, founder of The Prostate Education Project, about his personal journey through prostate cancer, recurrence, treatment decisions, and the mission that grew out of his experience.Michael shares what it was like to hear the words “you have prostate cancer,” why education became such an important part of his journey, and how clear information can help reduce fear for men, spouses, caregivers, and families facing prostate cancer.The conversation covers PSA testing, Gleason scores, prostate cancer recurrence after prostate removal, androgen deprivation therapy (ADT), ADT side effects, ADT holidays, intimacy and relationship challenges, and the importance of having a spouse, partner, or loved one present during medical appointments.Dr. Haley and Michael also discuss Michael's long history with Haley Nutrition's Aloe Vera Gel Health Drink as part of his personal wellness routine. Aloe vera is not presented as a cancer cure. Instead, this conversation focuses on education, supportive wellness, patient empowerment, and asking better questions when navigating serious health decisions.Michael's closing message is simple and powerful:Knowledge reduces fear.Understanding builds confidence.Education empowers patients.Episode Resources:The Prostate Education Projecthttps://theprostateeducationproject.org/Haley Nutrition Aloe Vera Gel Health Drinkhttps://haleynutrition.com/Dr. Haley Show Noteshttps://drhaley.com/Haley Nutritionhttps://haleynutrition.com/Episode Highlights:00:00 PSA testing and false positives00:39 Meet Michael Bovarnick of The Prostate Education Project02:50 How Dr. Haley and Michael first connected03:14 Michael's prostate cancer diagnosis and aloe vera story05:37 Important disclaimer about aloe vera and cancer08:05 Why prostate cancer can return after prostate removal10:54 Life today after prostate cancer recurrence12:18 Prostate cancer awareness and rising diagnosis rates13:36 PSA testing, screening, and Dr. Haley's personal story16:59 Hearing the words “you have prostate cancer”18:46 Intimacy, relationships, and emotional challenges23:10 What doctors explain — and what patients may miss26:22 Advice for newly diagnosed men in the panic phase28:33 PSA, Gleason score, and treatment decisions31:06 What is ADT? Androgen deprivation therapy explained32:45 ADT side effects doctors may not fully prepare you for34:51 Why you should bring a partner to appointments36:39 What is an ADT holiday?39:27 PSA testing advice for men over 4040:36 Urinary symptoms, enlarged prostate, and getting checked42:49 Prostate cancer symptoms beyond urinary problems43:52 Exercise, diet, bone health, and muscle health during ADT45:00 Exploring TheProstateEducationProject.org46:47 Spanish-language resources and community outreach48:32 Final thoughts: Knowledge reduces fearMedical Disclaimer:This podcast is for educational purposes only and is not medical advice. The information shared in this episode should not be used to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider regarding PSA testing, prostate cancer screening, diagnosis, medications, supplements, treatment options, or any health-related decisions.Aloe vera is discussed in this episode as part of Michael Bovarnick's personal wellness routine and experience. It is not presented as a treatment or cure for prostate cancer.About Michael Bovarnick:Michael Bovarnick is the founder of The Prostate Education Project, a growing educational resource created to help prostate cancer patients, spouses, caregivers, and families better understand the prostate cancer journey. His work focuses on clear explanations, practical tools, lived experience, and helping people know what questions to ask when facing diagnosis, treatment decisions, side effects, recurrence, and recovery.About Dr. Michael Haley:Dr. Michael Haley is the host of The Dr. Haley Show and founder of Haley Nutrition, known for producing raw, inner-leaf Aloe Vera Gel Health Drink and other natural wellness products. Through the podcast, Dr. Haley explores natural health, patient education, practical wellness strategies, and conversations that help listeners take a more informed role in their health journey.

As new data reshape treatment discussions for high-risk localized prostate cancer, understanding the nuances behind the evidence is critical. Ashley E. Ross, MD, PhD, a member of the PROTEUS (Perioperative Treatment with Erleada United with Surgery) steering committee, offers an insider's perspective on the landmark trial, including how it's adding options for standard of care.

In this episode of All Talk Oncology, host Kenny Perkins (Your Cancer Guy) sits down with legendary R&B artist Montell Jordan for an honest and deeply personal conversation about his battle with prostate cancer. Known worldwide for the iconic hit “This Is How We Do It,” Montell opens up about life beyond music and shares what it was like receiving a cancer diagnosis after a routine annual physical. Initially diagnosed with early-stage prostate cancer, Montell discusses the difficult decisions surrounding treatment, the emotional toll of recurrence, and how his unwavering faith helped him navigate one of the hardest battles of his life. Montell candidly speaks about the realities many men don't openly discuss—fear, masculinity, intimacy after treatment, mental resilience, and the impact cancer has on relationships and family dynamics. He also highlights the vital role caregivers play and how his wife helped sustain him through treatment and recovery. Most importantly, Montell emphasizes the life-saving importance of early detection and PSA screening, especially for African American men who are at higher risk for prostate cancer. This powerful episode is filled with encouragement, practical insight, and hope for patients, caregivers, survivors, and families navigating cancer. In this episode, Montell Jordan discusses the following: His life and career before cancer Receiving a prostate cancer diagnosis after a routine physical Why annual screenings and PSA testing matter Understanding Gleason scores and prostate cancer staging The treatment decision process: watch, treat, radiate, or remove Undergoing a radical prostatectomy Facing cancer recurrence and navigating proton therapy How faith shaped his mindset during treatment The emotional impact of cancer on spouses and caregivers Why empathy, not sympathy is critical during cancer care Intimacy and relationships after prostate cancer treatment Advocacy for men's health and prostate cancer awareness His documentary Sustain, chronicling his cancer journey The importance of early detection for saving lives Montell also reminds listeners that a cancer diagnosis does not have to define the rest of your story. With faith, medical care, family support, and early intervention, there is hope—and there is life after cancer. Immortalize your voice by being an ALL TALK ONCOLOGY GUEST! Just fill-out this FORM. Invite Kenny Perkins to Speak or Participate on your event. Just fill-out this FORM.   SOCIAL MEDIA LINKS: All Talk Oncology: Instagram & Facebook JOIN OUR FREE COMMUNITY: Facebook Community WEBSITE: www.alltalkoncology.com  

50:02- John Solomon, award-winning investigative journalist, founder of "Just The News," and the host of “Just the News, No Noise” on the Real America’s Voice network Topic: Trump Accounts; Graham Planter; Accused Charlie Kirk killer in court; Other news of the day 59:05- Hans von Spakovsky, Senior Legal Fellow in the new Edwin Meese III Institute for the Rule of Law at Advancing American Freedo Topic: Alleged Charlie Kirk assassin Tyler Robinson's court appearance 1:12:21- K.T. McFarland, Former Trump Deputy National Security Advisor and the author of "Revolution: Trump, Washington and 'We The People'” Topic: Current state of the U.S.-Israel relationship; Aftermath of negotiations in Doha 1:29:21- David Fischer, CEO of Landmark Capital Topic: Aggressive rise of stock indexes 1:40:47- Sheriff Shaun Golden, Monmouth County Sheriff Topic: BJ's roof collapse 1:48:53- Robert Greenway, Senior VP of American Global Strategies, Former Deputy Assistant to the President and Senior Director for the Middle East and North Africa in the Trump administration, and principal architect of the Abraham Accords Topic: Iranian performer calls for President Trump's assassination at Khamenei's funeral 2:01:23- Assemblywoman Dawn Fantasia, Republican representing New Jersey's 24th legislative district Topic: Why Mikie Sherrill hasn't called a State of Emergency in NJ 2:12:47- Dr. Gil Lederman, Expert in Prostate Cancer and the host of "Radiosurgery New York with Dr. Gil Lederman" on AM 970 The Answer Topic: His letter to the editor of the New York TimesSee omnystudio.com/listener for privacy information.

Dr. Ashwin Singh Parihar sits down with Dr. Louise Emmett to discuss how post-therapy Lutetium-177 PSMA SPECT/CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZA-p trial run by ANZUP cancer trials group, they explore quantitative imaging, treatment response assessment, adaptive dosing strategies, and the growing role of theranostics in precision oncology.   177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer. Ayati et al. Radiology 2026; 319(1):e252672.

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Pfizer. --- Timestamps 00:00 - Introduction02:51 - PARPi Basics14:12 - Major Study Differences19:00 - Timing and Selection of PARPi Combinations26:39 - Case: Somatic BRCA2 loss and mHSPC35:51 - Case Continued: BRCA2 Reversion39:57 - BRCAAway Study42:59 - Takeaways from the 2026 APCCC --- More about this episode The conversation reviews lessons learned from major clinical trials, including PROpel, MAGNITUDE, TALAPRO-2, and AMPLITUDE, and addresses how these studies inform real-world treatment choices. The doctors dig into case examples, such as BRCA2 loss and reversion, and highlight practical strategies for using germline and somatic testing to personalize care. Key insights from the 2026 Advanced Prostate Cancer Consensus Conference are also shared, emphasizing the importance of precision medicine in this rapidly evolving field. --- Resources Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (PROpel) https://clinicaltrials.gov/study/NCT03732820 A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer (MAGNITUDE) https://clinicaltrials.gov/study/NCT03748641?tab=study Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC (TALAPRO-2) https://clinicaltrials.gov/study/NCT03395197 A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (AMPLITUDE) https://clinicaltrials.gov/study/NCT04497844 BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) bearing homologous recombination-repair mutations (HRRm) https://pubmed.ncbi.nlm.nih.gov/39115414/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Is “watchful waiting” for prostate cancer really the safest path—or could it be creating more harm than help?Today on Intellectual Medicine, Dr. Stephen Petteruti challenges the conventional use of watchful waiting and active surveillance in prostate cancer management. He argues that prostate biopsies and many standard treatment strategies often do little to improve long-term survival while subjecting patients to significant physical, emotional, and psychological burdens.Dr. Petteruti explains why he believes prostate biopsies have become outdated, questions the benefits of repeated surveillance procedures, and explores the stress and uncertainty that can accompany living with the ongoing fear of disease progression.The conversation also examines the potential side effects of prostate surgery and radiation therapy, including their impact on sexual function, urinary control, and overall quality of life.Rather than relying exclusively on PSA testing, biopsies, and imaging to drive treatment decisions, Dr. Petteruti advocates for a more proactive approach, one focused on optimizing overall health, supporting immune function, and preserving vitality while navigating a prostate cancer diagnosis.Timestamps:(00:00) Why watchful waiting feels like “water torture”(00:32) Why Dr. Petteruti believes the era of prostate biopsy should end(01:24) The limitations of surgery and radiation in prostate cancer care(02:50) Why biopsies cannot predict future disease behavior(04:45) Active surveillance vs. true treatment(06:00) The problem with labeling prostate cancer as “low risk”(07:20) PSA testing, MRI scans, and monitoring over time(09:00) Who should decide how prostate cancer is managed?(10:21) Why PSA trends matter more than a single result(11:55) Concerns about the side effects of surgery and radiation(14:10) The psychological burden of watchful waiting(15:18) A different approach: functional active treatment(16:12) The Prostate Vitality community and patient support(17:34) Challenging conventional thinking about prostate cancer managementEnjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Book: Fight Cancer Like a Man: https://tinyurl.com/FightLikeAManBookDr. Steve's email newsletter: https://drstephenpetteruti.substack.com/subscribePodcast show notes : https://www.intellectualmedicine.com/podcast-notesMember exclusive content: https://tinyurl.com/DrPetterutiMemberLearn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠ Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠ Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.

Artificial intelligence is transforming prostate cancer care faster than ever before but could it one day replace the traditional biopsy?In this episode, Dr. Geo sits down with Dr. Wayne Brisbane, Assistant Professor of Urology and urologic oncologist whose research is helping redefine how prostate cancer is detected and treated. After earning his medical degree from Loma Linda University School of Medicine, completing his urology residency at the University of Washington, and a fellowship in Urologic Oncology at UCLA, Dr. Brisbane has become one of the leading voices in AI-driven prostate cancer diagnosis.His clinical practice and research focus on image-guided biopsy, MRI, PSMA PET imaging, micro-ultrasound, and focal therapy—helping patients receive more precise treatment while minimizing unnecessary side effects. UCLA remains one of the few centers in the world advancing all of these technologies under one program.Together, Dr. Geo and Dr. Brisbane explore how artificial intelligence is improving MRI interpretation, helping physicians better map prostate tumors, identify the best candidates for focal therapy, and potentially reduce the need for invasive biopsies in the future.If you're navigating a prostate cancer diagnosis or simply want to understand where prostate cancer care is headed this conversation offers a fascinating look at the next generation of precision medicine.Episode Chapters00:00 Introduction03:00 AI Is Changing Prostate Cancer Diagnosis07:00 Unfold AI: Mapping Tumors with Greater Precision10:00 Who Is the Right Candidate for Focal Therapy?13:00 Life After Focal Therapy: MRI, PSMA & Monitoring15:00 Focal Therapy vs. Surgery: What the Latest Research Shows21:00 Can AI Eventually Replace the Prostate Biopsy?25:00 Dr. Brisbane's Vision for the Future of Diagnosis29:00 Cribriform Disease: Identifying High-Risk Cancer32:00 Beyond DNA: How Proteomics May Transform Cancer CareKey Takeaways✅ How AI is making prostate cancer diagnosis more accurate✅ Why MRI can still miss clinically significant prostate cancer✅ The technology behind Unfold AI and personalized tumor mapping✅ Who is—and isn't—a good candidate for focal therapy✅ Why tumor size plays a critical role in treatment decisions✅ Can AI eventually replace the prostate biopsy?✅ The latest research comparing focal therapy and surgery✅ Why prospective clinical trials matter when evaluating new treatments✅ How MRI, PSMA PET, genomics, and AI are shaping the future of prostate cancer care✅ Dr. Wayne Brisbane's vision for the next generation of precision prostate cancer diagnosisResources MentionedUnfold AI (Avenda Health)MRI for prostate cancerPSMA PET imagingFocal TherapyActive SurveillanceUCLA Prostate Cancer ResearchStanford validation studiesCAPTAIN TrialFARP TrialHIFU clinical studies___________________________________

Summary:Brad Corley was diagnosed with stage 4 prostate cancer (Gleason 9) on December 10, 2021 — one day after retiring from a 38-year career. After bone scans and consultation with a New Orleans oncologist, the cancer was deemed metastatic and incurable but treatable; doctors gave him a 3-7 year outlook. Brad and his wife Becky had already begun shifting toward healthier living before the diagnosis, and immediately doubled down — adopting a raw, plant-based diet and daily carrot juicing (inspired by Chris Beat Cancer/Square One) starting just two days after the diagnosis. Brad underwent hormone therapy and surgery through an MD Anderson clinical trial. Over two and a half years, he dropped from about 240 to about 170 pounds, regained energy, and his oncologist reportedly told him he shows no evidence of disease. The couple credits their faith, gratitude practice, and community support — they started a Healing Strong group in Mobile, Alabama, with around 12-15 regular members, many of whom don't have cancer but joined proactively. The episode closes with their message to newly diagnosed listeners: lean on faith, build a supportive community, and pursue lifestyle changes alongside medical treatment.HealingStrong's mission is to educate, equip and empower our group leaders and group participants through their journey with cancer or other chronic illnesses, and know there is HOPE. We bring this hope through educational materials, webinars, guest speakers, conferences, community small group support and more.Please take advantage of our FREE resources below to help you along your health and healing journey:Support Group DirectoryHolistic Curriculum - Participant GuideSupport Our Mission - DonateAdditional Health ResourcesListen to Previous EpisodesWebsite: healingstrong.org

Featuring an interview with Dr Rana R McKay, including the following topics: Prostate Cancer Working Group (PCWG4) revised terminology (0:00) Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17) Combination therapy using relugolix; factors affecting persistence and adherence to GnRH agents (12:06) Takeaways from the Phase III EMBARK study (19:36) Use of CAR (chimeric antigen receptor) T-cell therapy and T-cell engagers (27:20) Potential role of circulating tumor DNA minimal residual disease testing; use of olaparib/radium-223 (29:24) CME information and select publications

Featuring a slide presentation and related discussion from Dr Rana R McKay, including the following topics: Overview of the current landscape of prostate cancer (0:00) Mechanism of action of androgen deprivation therapy (ADT) (3:51) Findings from the Phase III HERO study evaluating relugolix versus leuprolide for advanced prostate cancer (7:18) Real-world evidence regarding the use of relugolix (12:27) Adverse event profile associated with ADT (18:34) Case: A man in his early 70s with metastatic hormone-sensitive prostate cancer who receives ADT at various timepoints of treatment and is currently on relugolix (21:46) Case: A man in his early 60s with high-risk locally advanced prostate cancer who receives various androgen receptor pathway inhibitors in addition to relugolix (28:06) CME information and select publications

Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology, Dr. Ruchi Talwar interviews Dr. Kirsten Greene about how advanced imaging is influencing decisions for radical prostatectomy. They examine the strengths and limits of PSMA PET, the risks and benefits of PLND, and why careful, evidence-based decision-making remains essential. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction03:12 - Risk Calculators and Consent04:39 - Nomograms vs. Complications09:57 - Endpoints That Matter11:38 - PSMA PET Strengths and Limits13:51 - Negative PET Decision-Making15:08 - Positive PET and Multimodal Care18:02 - Fluorescence Guided Surgery19:10 - Counseling on Complications22:27 - Preventing Lymphocele24:56 - How Lahey Wrap Works26:45 - Future Mapping and Therapy28:47 - Research Gaps and Dogma31:07 - Key Pearls and Wrap Up --- More about this episode Dr. Greene explains her approach using MSK and Briganti nomograms alongside PSMA PET, noting that PET scans may miss small nodal disease and quality varies between centers. She emphasizes PLND as a staging tool rather than a curative procedure, outlining potential complications like lymphocele, lymphedema, vascular and ureteral injury, and neuropraxia. The episode highlights her shared decision-making process, surgical techniques for limiting risk, and the importance of multimodal planning, especially for PET-positive nodal disease. Dr. Greene also shares practical tips for lymphocele prevention, including the use of metal clips and the Lahey wrap. --- Resources Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysishttps://pubmed.ncbi.nlm.nih.gov/36872312/ Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/33865797/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Brian Custer.

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Brian Custer.